Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
The purpose of the study is to compare the safety and efficacy of Prograf versus placebo in the prevention of erectile dysfunction in men after a bilateral nerve-sparing radical prostatectomy.
Age
0–65
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Male scheduled to undergo bilateral nerve sparing radical prostatectomy for prostate cancer.
You may not be if
Patient is \> 65 years of age
Patient has been diagnosed with Type 1 or Type 2 diabetes
Patient is actively smoking on a daily basis
Clareo Health | A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
